skip to content

Cambridge Cardiovascular

 

Clinical trials are research studies that help us to understand how to treat a particular disease or condition. Trials explore whether a treatment, medical strategy or device is safe and effective in people.

We have listed below some of the ongoing trials you can volunteer for.  Click on links for contact details. In most cases, trial organisers will reimburse your travel costs. The full list of ongoing clinical trials run by the Addenbrooke's Centre for Clinical Investigation can be found here.

Intensity-Low: This trial studies the effects of lowering LDL cholesterol on vascular health. You can take part if you are male or female, aged 18-45, and healthy.

Intensity-High: This trial studies the effects of lowering LDL cholesterol on vascular function. You can take part if you are male, aged 40 or over, and have stable cardiovascular disease.

DEFINE: This trial studies the role of two proteins in the prevention of type 2 diabetes and its complications. You can take part if you are male or female, aged 18 or over, and overweight (BMI 25-34.9).

AimHY: This trial aims to find the best blood pressure treatment for each individual. You can take part if you are male or female, aged 18-65, and have hypertension (high blood pressure).

LILACS: This trials aims to test the role of low-dose drug in the prevention of future heart attacks. You can take part if you are male or female, aged 18-75, and have had a heart attack (at least 6 months ago).

 

Cambridge Cardiovascular logo - transparent

We connect cardiovascular researchers in Cambridge.

Please follow us on Twitter for local news about research, events, funding calls, and open positions.

For inquiries about our research, please contact Dr Jane Sugars

For enquiries about our website or joining Cambridge Cardiovascular, please contact Denise Hatherly

Cambridge Cardiovascular on You Tube

Follow us

You must be logged into X to see our feed

 

Cambridge Cardiovascular Logo design by Dr Ana-Mishel Spiroski and Dr Sarah Morgan.